EuroEyes International Eye Clinic Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

EuroEyes International Eye Clinic wird ein jährliches Gewinn- und Umsatzwachstum von 16.9% bzw. 14.9% prognostiziert.

Wichtige Informationen

16.9%

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum	19.3%
Wachstumsrate der Einnahmen	14.9%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	03 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

EuroEyes International Eye Clinic (HKG:1846) Is Reducing Its Dividend To HK$0.0489

Jun 09

EuroEyes International Eye Clinic (HKG:1846) Is Paying Out Less In Dividends Than Last Year

May 09

Earnings Tell The Story For EuroEyes International Eye Clinic Limited (HKG:1846) As Its Stock Soars 27%

May 06

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

Apr 25

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

Mar 31

What Is EuroEyes International Eye Clinic Limited's (HKG:1846) Share Price Doing?

Nov 21

Analysts Have Just Cut Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Estimates By 15%

Sep 08

EuroEyes International Eye Clinic Limited (HKG:1846) Shares Could Be 24% Below Their Intrinsic Value Estimate

Jul 31

Analysts Just Made A Major Revision To Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Forecasts

Apr 25

There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

Dec 05

EuroEyes International Eye Clinic (HKG:1846) Will Pay A Larger Dividend Than Last Year At HK$0.099

May 26

EuroEyes International Eye Clinic's (HKG:1846) Upcoming Dividend Will Be Larger Than Last Year's

May 12

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Increased To HK$0.099

Apr 27

EuroEyes International Eye Clinic (HKG:1846) Is Increasing Its Dividend To HK$0.099

Apr 08

Slowing Rates Of Return At EuroEyes International Eye Clinic (HKG:1846) Leave Little Room For Excitement

Mar 07

Is Now An Opportune Moment To Examine EuroEyes International Eye Clinic Limited (HKG:1846)?

Jan 18

The Returns At EuroEyes International Eye Clinic (HKG:1846) Aren't Growing

Nov 02

There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

May 20

Is There An Opportunity With EuroEyes International Eye Clinic Limited's (HKG:1846) 42% Undervaluation?

Mar 29

Gewinn- und Umsatzwachstumsprognosen

SEHK:1846 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (HKD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,126	216	146	352	1
12/31/2025	994	208	141	350	2
12/31/2024	858	175	103	274	2
12/31/2023	714	131	102	192	N/A
9/30/2023	678	121	116	192	N/A
6/30/2023	641	110	129	192	N/A
3/31/2023	626	100	141	201	N/A
12/31/2022	610	89	153	209	N/A
9/30/2022	620	102	163	224	N/A
6/30/2022	629	115	172	238	N/A
3/31/2022	631	124	201	256	N/A
12/31/2021	633	134	229	273	N/A
9/30/2021	619	123	200	245	N/A
6/30/2021	605	113	171	217	N/A
3/31/2021	539	89	105	148	N/A
12/31/2020	474	66	40	78	N/A
9/30/2020	443	38	28	59	N/A
6/30/2020	412	10	16	39	N/A
3/31/2020	426	5	8	34	N/A
12/31/2019	430	-3	35	64	N/A
3/31/2019	389	23	74	91	N/A
12/31/2018	385	34	137	157	N/A
12/31/2017	347	82	45	83	N/A
12/31/2016	248	19	N/A	-3	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 1846Das prognostizierte Gewinnwachstum (16.9% pro Jahr) liegt über der Sparquote (2.2%).

Ertrag vs. Markt: 1846Die Erträge des Unternehmens (16.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (12% pro Jahr).

Hohe Wachstumserträge: 1846Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: 1846Die Einnahmen des Unternehmens (14.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (7.9% pro Jahr).

Hohe Wachstumseinnahmen: 1846Die Einnahmen des Unternehmens (14.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von 1846 in 3 Jahren voraussichtlich hoch sein wird

EuroEyes International Eye Clinic Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased by 23% to HK$7.26

Consensus revenue estimates fall by 15%

Price target increased by 13% to HK$7.16

Consensus revenue estimates increase by 25%, EPS downgraded

Price target decreased to HK$5.05

Price target decreased to HK$10.62

Recent updates

EuroEyes International Eye Clinic (HKG:1846) Is Reducing Its Dividend To HK$0.0489

Euroeyes International Eye Clinic Limited Declares the Final Dividend for the Year Ended 31 December 2023

Upcoming dividend of HK$0.049 per share

EuroEyes International Eye Clinic (HKG:1846) Is Paying Out Less In Dividends Than Last Year

Earnings Tell The Story For EuroEyes International Eye Clinic Limited (HKG:1846) As Its Stock Soars 27%

Investor sentiment improves as stock rises 16%

EuroEyes International Eye Clinic Limited, Annual General Meeting, Jun 06, 2024

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

VP of Denmark & Executive Director recently bought HK$835k worth of stock

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Reduced To HK$0.0489

EuroEyes International Eye Clinic Limited Proposes Final Ordinary Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024

New minor risk - Financial data availability

EuroEyes International Eye Clinic Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

VP of Denmark & Executive Director recently bought HK$478k worth of stock

Price target decreased by 23% to HK$7.26

Founder recently bought HK$215k worth of stock

What Is EuroEyes International Eye Clinic Limited's (HKG:1846) Share Price Doing?

Investor sentiment improves as stock rises 21%

Founder recently bought HK$448k worth of stock

Analysts Have Just Cut Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Estimates By 15%

Consensus revenue estimates fall by 15%

Founder recently bought HK$54k worth of stock

Upcoming dividend of HK$0.051 per share at 2.1% yield

First half 2023 earnings released: EPS: HK$0.20 (vs HK$0.14 in 1H 2022)

EuroEyes International Eye Clinic Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 28 September 2023

EuroEyes International Eye Clinic Limited to Report First Half, 2023 Results on Aug 29, 2023

EuroEyes International Eye Clinic Limited (HKG:1846) Shares Could Be 24% Below Their Intrinsic Value Estimate

Now 20% undervalued after recent price drop

Upcoming dividend of HK$0.063 per share at 1.3% yield

Now 23% undervalued after recent price drop

Price target increased by 13% to HK$7.16

Analysts Just Made A Major Revision To Their EuroEyes International Eye Clinic Limited (HKG:1846) Revenue Forecasts

Now 22% undervalued after recent price drop

Consensus revenue estimates increase by 25%, EPS downgraded

Full year 2022 earnings released: EPS: HK$0.27 (vs HK$0.41 in FY 2021)

Founder recently bought HK$910k worth of stock

Founder recently bought HK$4.4m worth of stock

Euroeyes International Eye Clinic Limited Announces Resignation of Ralf-Christian Lerche as an Executive Director

Founder recently bought HK$111k worth of stock

Founder recently bought HK$90k worth of stock

There Are Reasons To Feel Uneasy About EuroEyes International Eye Clinic's (HKG:1846) Returns On Capital

Price target decreased to HK$5.05

Less than half of directors are independent

Founder recently bought HK$297k worth of stock

Founder recently bought HK$345k worth of stock

Founder recently bought HK$364k worth of stock

Founder recently bought HK$1.0m worth of stock

Price target decreased to HK$10.62

Founder recently bought HK$546k worth of stock

Founder recently bought HK$474k worth of stock

Founder recently bought HK$976k worth of stock

Founder recently bought HK$1.3m worth of stock

Founder recently bought HK$538k worth of stock

First half 2022 earnings released: EPS: HK$0.14 (vs HK$0.20 in 1H 2021)

EuroEyes International Eye Clinic Limited to Report First Half, 2022 Results on Aug 24, 2022

Founder recently bought HK$600k worth of stock

Founder recently bought HK$383k worth of stock

Euroeyes International Eye Clinic Limited Appoints Dan Zoltan Reinstein as Executive Director

Investor sentiment improved over the past week

Euroeyes International Eye Clinic Limited Approves Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.099 per share

EuroEyes International Eye Clinic (HKG:1846) Will Pay A Larger Dividend Than Last Year At HK$0.099

Founder recently bought HK$1.3m worth of stock

EuroEyes International Eye Clinic's (HKG:1846) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS misses analyst expectations

EuroEyes International Eye Clinic's (HKG:1846) Dividend Will Be Increased To HK$0.099

Less than half of directors are independent

EuroEyes International Eye Clinic (HKG:1846) Is Increasing Its Dividend To HK$0.099

Founder recently bought HK$724k worth of stock